Literature DB >> 192088

Cyclic AMP in action of antidiuretic hormone: effects of exogenous cyclic AMP and its new analogue.

D A Hall, L D Barnes, T P Dousa.   

Abstract

Exogenous cyclic 3',5'-adenosine monophosphate (cAMP) stimulates the effect of the antidiuretic hormone, vasopressin (VP), only in pharmacologic quantities and results have often been inconsistent. The present study examined the ability of a new analogue, 8-[p-Cl-phenylthio]cyclic 3',5'-adenosine monophosphate (C1-PheS-cAMP) to mimic the effect of VP, both biochemically (protein kinase activation) and functionally (hydrosomatic response of perfused collecting tubules) in mammalian kidney tissue. C1PheS-cAMP was found to be about 100 times as effective as cAMP both biochemically and functionally. The increased effectiveness of C1PheS-cAMP is probably is probably due to a greater permeability across the cell membrane and to the resistance of C1PheS-cAMP to enzymatic degradation, Cyclic AMP phosphodiesterase inhibition was observed with C1PheS-cAMP, but its contribution to overall effect was minor. C1PheS-cAMP was found to be more effective than exogenous vasopressin, an effect probably due primarily to its resistance to catabolism. The results provide further new evidence that cAMP and protein kinase are involved in the cellular action of vasopressin. C1PheS-cAMP proved to be a useful tool in the study of hormone action, especially in steps subsequent to cAMP generation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192088     DOI: 10.1152/ajprenal.1977.232.4.F368

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Effect of nocodazole on the water permeability response to vasopressin in rabbit collecting tubules perfused in vitro.

Authors:  M E Phillips; A Taylor
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

2.  Functional profile of the isolated uremic nephron. Impaired water permeability and adenylate cyclase responsiveness of the cortical collecting tubule to vasopressin.

Authors:  L G Fine; D Schlondorff; W Trizna; R M Gilbert; N S Bricker
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

3.  Modulation of cyclic nucleotides in islated rat glomeruli: role of histamine, carbamylcholine, parathyroid hormone, and angiotensin-II.

Authors:  V E Torres; T E Northrup; R M Edwards; S V Shah; T P Dousa
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

4.  Effects of vasopressin on water and NaCl transport across the in vitro perfused medullary thick ascending limb of Henle's loop of mouse, rat, and rabbit kidneys.

Authors:  S Sasaki; M Imai
Journal:  Pflugers Arch       Date:  1980-02       Impact factor: 3.657

5.  Dibutyryl cyclic AMP inhibits transport dependent QO2 in cells isolated from the rabbit medullary ascending limb.

Authors:  P Silva; B Koenig; S Lear; J Eveloff; R Kinne
Journal:  Pflugers Arch       Date:  1987-06       Impact factor: 3.657

6.  Inhibition of the antidiuretic hormone hydroosmotic response by phospholipids and phospholipid metabolites.

Authors:  N Tarapoom; R Royce; T Yorio
Journal:  Lipids       Date:  1986-09       Impact factor: 1.880

7.  Ca2+ entry through the apical membrane reduces antidiuretic hormone-induced hydroosmotic response in toad urinary bladder.

Authors:  W Van Driessche; D Erlij; I Aelvoet
Journal:  Pflugers Arch       Date:  1990-11       Impact factor: 3.657

8.  Urinary concentrating defect of adrenal insufficiency. Permissive role of adrenal steroids on the hydroosmotic response across the rabbit cortical collecting tubule.

Authors:  M J Schwartz; J P Kokko
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

9.  Isolated nephron segments from rabbit models of obstructive nephropathy.

Authors:  M J Hanley; K Davidson
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

10.  In vivo and in vitro studies of urinary concentrating ability in potassium-depleted rabbits.

Authors:  K H Raymond; K K Davidson; T D McKinney
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.